| |
|
|
|
BioCryst Pharmaceuticals Inc.  
|
|
5.435 -0.09 (-0.02%) |
07-10 16:00 |
|
Open: |
5.5468 |
Pre close: |
5.525 |
Target:
|
7.04
|
|
High: |
5.6 |
Low: |
5.24 |
Resistance:
|
6.03
7.04
|
|
Volume: |
5,566,505 |
Market Cap: |
959M |
Support:
|
4.68
3.84
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.35
 |
MACD |
MACD(12,26):
|
0.27 |
|
MA(20): |
4.67 |
Signal(12,26,9): |
0.17 |
|
MA(100): |
3.63 |
Stochastic Oscillator |
%K(14,3):
|
74.20  |
|
MA(250): |
3.13 |
%D(3): |
78.23 |
|
Average Volume(K) |
3-Month: |
1096132
|
52-Week |
High:
|
6.29 |
|
10-Days: |
960954 |
Low: |
1.38 |
|
RSI |
RSI(14):
|
64.32 |
Change(%): |
51.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.912 |
Return on Equity (ttm) |
-882.8 |
Shares Out. (M) |
176.40 |
|
EPS Est. Current Year |
-0.750 |
Return on Assets (ttm) |
-49.8 |
Shares Float (M) |
135.46 |
|
EPS Est. Next Year |
-0.780 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.95 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
-18.1 |
% Held by Institutions |
90.20 |
|
Forward EPS |
-0.940 |
Gross Profit (p.s.) |
-0.353 |
Shares Short (K) |
20630 |
|
Book Value (p.s.) |
0.020 |
EBITDA (p.s.) |
-0.626 |
P/E |
-5.96 |
|
Sales Per Share |
0.271 |
Qtrly Earnings Growth |
0.00 |
P/BV |
271.75 |
|
Profit Margin |
-241.66 |
Operating Cash Flow
(M) |
-85.87 |
P/S |
20.07 |
|
Operating Margin |
-232.57 |
Levered Free Cash Flow
(M) |
-47.20 |
P/CF |
-11.16 |
|
|
|
|
|
|
